Cold Spring Harbor Laboratory's Animal Shared Resource consists of two separate facilities that house and support research animals for use by the Cancer Center's research investigators. These facilities consist of the Harris Research Support Shared Resource, located on the Laboratory's main campus, and the Woodbury Research Support Shared Resource, currently under construction and located within the Laboratory's Woodbury Genome Center. This modern facility is specifically designed to maintain animals under pathogen free conditions. The CSHL Cancer Center Animal Shared Resource is used by most of the scientific staff at the Laboratory. Usage of the Shared Resource can be subdivided into three categories based on the research needs of the individual investigators: antibody production, the generation of transgenic animals, and housing animals. The Resource was used at about 90% capacity over the last year. Approximately 80% of the use of the Harris Animal Shared Resource was by members of the Cancer Center. The CCSG provided 24% of the income to the Shared Resource, while 76% of the income was provided by core billing charge backs. The use of the Animal Shared Resource divided almost evenly among members of the three different programs (Gene expression, Cell Biology and Cancer Genetics)) in the Cancer Center). Significant improvements to the Animal Shared Resource over the net funding period will be the expansion into the second Woodbury Research Support Shared Resource and the provision of additional services relating to the use of animal models for cancer research.
Kumar, Vijay; Rosenbaum, Julie; Wang, Zihua et al. (2018) Partial bisulfite conversion for unique template sequencing. Nucleic Acids Res 46:e10 |
Lee, Je H (2018) Tracing single-cell histories. Science 359:521-522 |
Alexander, Joan; Kendall, Jude; McIndoo, Jean et al. (2018) Utility of Single-Cell Genomics in Diagnostic Evaluation of Prostate Cancer. Cancer Res 78:348-358 |
Huang, Yu-Han; Klingbeil, Olaf; He, Xue-Yan et al. (2018) POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev 32:915-928 |
Tiriac, Hervé; Belleau, Pascal; Engle, Dannielle D et al. (2018) Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov 8:1112-1129 |
Naguib, Adam; Mathew, Grinu; Reczek, Colleen R et al. (2018) Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells. Cell Rep 23:58-67 |
Forcier, Talitha L; Ayaz, Andalus; Gill, Manraj S et al. (2018) Measuring cis-regulatory energetics in living cells using allelic manifolds. Elife 7: |
Bhagwat, Anand S; Lu, Bin; Vakoc, Christopher R (2018) Enhancer dysfunction in leukemia. Blood 131:1795-1804 |
Aberle, M R; Burkhart, R A; Tiriac, H et al. (2018) Patient-derived organoid models help define personalized management of gastrointestinal cancer. Br J Surg 105:e48-e60 |
Chen, Wei-Chia; Tareen, Ammar; Kinney, Justin B (2018) Density Estimation on Small Data Sets. Phys Rev Lett 121:160605 |
Showing the most recent 10 out of 380 publications